These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 3812468)

  • 1. An autoantibody with potent antithrombin activity whose action could be inhibited by toluidine blue or methylene blue.
    Shojania AM; Meilleur G; Alvi AW
    Am J Hematol; 1987 Feb; 24(2):207-14. PubMed ID: 3812468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of toluidine blue and methylene blue in immunochemical reactions in vitro.
    Shojania AM; Orr K
    Clin Immunol Immunopathol; 1987 May; 43(2):223-8. PubMed ID: 3494558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function.
    Chouhan VD; De La Cadena RA; Nagaswami C; Weisel JW; Kajani M; Rao AK
    Thromb Haemost; 1997 Feb; 77(2):343-9. PubMed ID: 9157594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tsetse (Glossina morsitans morsitans Westw.) (Diptera: Glossinidae) salivary gland homogenate on coagulation and fibrinolysis.
    Parker KR; Mant MJ
    Thromb Haemost; 1979 Aug; 42(2):743-51. PubMed ID: 505376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature of the anticoagulant effect of heparin, protamine, polybrene and toluidine blue.
    OLLENDORFF P
    Scand J Clin Lab Invest; 1962; 14():267-76. PubMed ID: 14481859
    [No Abstract]   [Full Text] [Related]  

  • 6. An acquired inhibitor that produced a delay of fibrinopeptide B release in an asymptomatic patient.
    Llobet D; Borrell M; Vila L; Vallvé C; Felices R; Fontcuberta J
    Haematologica; 2007 Feb; 92(2):e17-9. PubMed ID: 17405747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of cation dyes on blood coagulation].
    Chepurov AK; Lazarenko GI
    Biull Eksp Biol Med; 1977 Sep; 84(9):279-82. PubMed ID: 912078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An acquired antithrombin autoantibody directed toward the catalytic center of the enzyme.
    Sié P; Bezeaud A; Dupouy D; Archipoff G; Freyssinet JM; Dugoujon JM; Serre G; Guillin MC; Boneu B
    J Clin Invest; 1991 Jul; 88(1):290-6. PubMed ID: 1711542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heparin neutralization with methylene blue, hexadimethrine, or vancomycin after cardiopulmonary bypass.
    Kikura M; Lee MK; Levy JH
    Anesth Analg; 1996 Aug; 83(2):223-7. PubMed ID: 8694296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A COAGULATION ANOMALY: PLASMA BEING MADE NON-CLOTTABLE BY ADDING THROMBIN, AND CLOTTABLE BY THROMBOPLASTIN-CALCIUM OR TOLUIDINE BLUE-THROMBIN.V5 BLUE-THROMBIN.
    MAKI M; KIKUCHI K; WATANABE S; KIKUCHI E
    Tohoku J Exp Med; 1964 Dec; 84():274-81. PubMed ID: 14244484
    [No Abstract]   [Full Text] [Related]  

  • 11. Tumor immunoglobulin with antibody activity against blood coagulation factors.
    Antonucci M; Berard M; Beaumont JL
    J Med; 1986; 17(3-4):149-65. PubMed ID: 3473163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant activities of a monoclonal antibody that binds to exosite II of thrombin.
    Lian F; He L; Colwell NS; Lollar P; Tollefsen DM
    Biochemistry; 2001 Jul; 40(29):8508-13. PubMed ID: 11456488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation and characterization of an acquired antithrombin antibody.
    Lawson JH; Pennell BJ; Olson JD; Mann KG
    Blood; 1990 Dec; 76(11):2249-57. PubMed ID: 2257299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticoagulant activity of a bacterial glycopeptide.
    Akoum A; Josefonvicz J; Sigot M
    Thromb Res; 1990 Oct; 60(1):9-18. PubMed ID: 2126150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partial characterization of an autoantibody recognizing the secondary binding site(s) of thrombin in a patient with recurrent spontaneous arterial thrombosis.
    Costa JM; Fiessinger JN; Capron L; Aiach M
    Thromb Haemost; 1992 Feb; 67(2):193-9. PubMed ID: 1320300
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interaction of lipopolysaccharides with phenothiazine dyes.
    Usacheva MN; Teichert MC; Biel MA
    Lasers Surg Med; 2003; 33(5):311-9. PubMed ID: 14677158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effect of toluidine blue and methylene blue on rat mast cell damage by promethazine, chlorpromethazine and chlorpromazine. Its reversal by glucose.
    Vugman I; Gomez Rodrigues JM
    Experientia; 1974 Oct; 30(10):1178-80. PubMed ID: 4140101
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of toluidine blue on the coagulation of fibrinogen by thrombin.
    HALEY TJ; RHODES B
    Science; 1953 May; 117(3048):604-6. PubMed ID: 13056632
    [No Abstract]   [Full Text] [Related]  

  • 19. Study of the fibrinolytic process in a patient with antiphospholipid syndrome.
    Marchi R; Garmendia J; Kanzler D; Fuenmayor J
    Blood Coagul Fibrinolysis; 2015 Apr; 26(3):239-45. PubMed ID: 24418942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A patient with a spontaneous factor VIII:C autoantibody: successful treatment with cyclosporine.
    Hart HC; Kraaijenhagen RJ; Kerckhaert JA; Verdel G; Freen M; van de Wiel A
    Transplant Proc; 1988 Jun; 20(3 Suppl 4):323-8. PubMed ID: 3132776
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.